SOPHiA GENETICS SA filed its Form 6-K on November 4, 2025, reporting financial results for the nine months ended September 30, 2025.
FINANCIAL PERFORMANCE (9 Months Ended Sept 30, 2025) Revenue grew 17 percent year over year to \(55.6 million. Q3 saw \)19.5 million in revenue, marking the third consecutive quarter of 23 percent year over year growth. The Operating Loss widened to (\(52.4 million) from (\)49.1 million) in 2024, attributed to increased Research and Development and Sales and Marketing costs. The total comprehensive loss was ($48.3 million), resulting in a diluted loss per share of (
...